Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report 2026

Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview

• Messenger Ribonucleic Acid (MRNA) Manufacturing Service market size has reached to $6.14 billion in 2025 • Expected to grow to $12.97 billion in 2030 at a compound annual growth rate (CAGR) of 16.2% • Growth Driver: Rising Clinical Trial Activity Driving Growth Of The Market Due To Increasing Demand For Rapid And Flexible Mrna Production • Market Trend: Innovations in IVT-Based mRNA Manufacturing Services Accelerating Preclinical And IND-Enabling Drug Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?

Messenger ribonucleic acid (mRNA) manufacturing service refers to contract or in-house services that produce high-quality mRNA molecules for therapeutic or vaccine applications. These services include design, synthesis, purification, and quality control of mRNA, often tailored for lipid nanoparticle delivery systems. It helps to enable the production of safe and effective mRNA-based therapeutics and vaccines for research, clinical trials, and commercial deployment. The main service types of messenger ribonucleic acid (mRNA) manufacturing service include process development, analytical testing, manufacturing, fill-finish, and other service types. Process development refers to services that optimize and establish scalable mRNA production processes for research, clinical, and commercial purposes. The scales of operation include research and preclinical scale, clinical scale, and commercial scale. The applications include vaccines, therapeutics, research, and other applications, and the end users are pharmaceutical and biotechnology companies, academic and research institutes, and other end users.

What Is The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Growth Forecast?

The messenger ribonucleic acid (mrna) manufacturing service market size is expected to see rapid growth in the next few years. It will grow to $12.97 billion in 2030 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to increase in mrna therapy trials, expansion of contract manufacturing demand, growth in personalized medicine, higher outsourcing by biotech firms, scale up of commercial mrna products. Major trends in the forecast period include integrated mrna process development services, large scale in vitro transcription production, end to end lnp encapsulation services, rapid technology transfer programs, gmp grade mrna batch manufacturing.

Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Segmentation

1) By Service Type: Process Development; Analytical Testing; Manufacturing; Fill-Finish; Other Service Types 2) By Scale of Operation: Research And Preclinical Scale; Clinical Scale; Commercial Scale 3) By Application: Vaccines; Therapeutics; Research; Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users Subsegments: 1) By Process Development: Template Design And Optimization; In Vitro Transcription Process Design; Formulation Development; Process Scale-Up And Technology Transfer; Process Validation Support 2) By Analytical Testing: Identity And Purity Testing; Potency And Functional Assays; Impurity And Contaminant Analysis; Stability And Shelf Life Studies; Quality Control Release Testing 3) By Manufacturing: Plasmid Deoxyribonucleic Acid Production; In Vitro Transcription Manufacturing; Enzymatic Capping And Tailoring; Purification And Concentration; Large-Scale Batch Production 4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Labeling And Packaging; Cold Chain Handling And Storage 5) By Other Service Types: Regulatory Support Services; Quality Assurance And Documentation; Supply Chain And Logistics Support; Technology Consulting Services; Custom Manufacturing Solutions

What Is The Driver Of The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?

The rising clinical trial activity is expected to propel the growth of the messenger ribonucleic acid (mRNA) manufacturing service market going forward. Clinical trial activity refers to all processes involved in conducting and managing clinical studies to evaluate medical interventions in humans. Clinical trial activity is increasing due to the rising adoption of digital and decentralized trial models, which enable faster patient recruitment, remote monitoring, and more efficient data collection across broader populations. Messenger ribonucleic acid (mRNA) manufacturing services aid clinical trial activity by ensuring rapid and flexible production of mRNA-based therapies, allowing timely supply for multiple trial phases and accelerating drug development. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, the number of industry clinical trials initiated in the UK increased to 426 in 2023, from 411 in 2022. Therefore, the rising clinical trial activity is driving the growth of the messenger ribonucleic acid (mRNA) manufacturing service industry.

Key Players In The Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

Major companies operating in the messenger ribonucleic acid (mrna) manufacturing service market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Biotechnologies, Evonik Industries AG, Lonza Group AG, Charles River Laboratories International Inc., Samsung Biologics Co. Ltd., WuXi Biologics Inc., Recipharm AB, Curia Global Inc., Emergent BioSolutions Inc., AGC Biologics Inc., Corden Pharma International GmbH, Rentschler Biopharma SE, GenScript ProBio, ST Pharm Co. Ltd., etherna Immunotherapies NV, BIOMAY AG., Porton Advanced Solutions Ltd., Wacker Biotech GmbH.

Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Trends and Insights

Major companies operating in the messenger ribonucleic acid (mRNA) manufacturing service market are focusing on developing innovative solutions, such as in vitro transcription (IVT), to accelerate the production of high-quality, clinical-grade mRNA for vaccines and personalized therapies. In vitro transcription (IVT) refers to a laboratory process that synthesizes messenger RNA (mRNA) from a DNA template using RNA polymerase enzymes, enabling the production of mRNA outside of living cells for research, therapeutic, or vaccine applications. For instance, in May 2025, GenScript Biotech Corporation, a China-based biotechnology company, launched a GMP-like mRNA manufacturing service to support preclinical studies and IND-enabling research. The solution provides high-purity, scalable in vitro transcription (IVT) processes with stringent control over critical quality attributes such as capping efficiency, poly(A) tail length, and impurity profiles. It supports rapid transition from preclinical to clinical stages by enabling consistent batch-to-batch production, flexible customization for different mRNA constructs, and reduced development timelines. In addition, the GMP-like framework ensures regulatory readiness through enhanced traceability, standardized workflows, and comprehensive quality documentation, helping developers de-risk later-stage manufacturing and accelerate clinical progress.

What Are Latest Mergers And Acquisitions In The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?

In December 2025, BioNTech SE, a Germany-based biotechnology company, acquired CureVac N.V. for an undisclosed amount. With this acquisition, BioNTech aims to strengthen its unique position in the mRNA field by acquiring CureVac to enhance mRNA design, delivery, manufacturing, and commercialization capabilities, particularly advancing oncology programs like cancer immunotherapies and BNT327. CureVac N.V. is a Germany-based company that provides mRNA development and manufacturing services for therapeutic and vaccine applications.

Regional Insights

North America was the largest region in the mRNA manufacturing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?

The messenger ribonucleic acid (mRNA) manufacturing service market includes revenues earned by entities through the regulatory support, technology transfer, supply chain management, design and synthesis, purification, scale-up services, encapsulation services, plasmid production, quality control testing, product characterization services, formulation development, lipid nanoparticle (LNP) formulation services, and cold chain logistics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report 2026?

The messenger ribonucleic acid (mrna) manufacturing service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) manufacturing service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.